Xiaomei Bs Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaomei Bs Tang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chunmei Bs Wang
Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
2 shared publications - Jing Yan
Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
2 shared publications - Sheng Xie
The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
2 shared publications - Bingjie Bs Han
Graduate School of Guangxi University of Chinese Medicine, Nanning City, China
1 shared publication Jiaqi Li
Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
1 shared publication- Jinjing Tan
The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
1 shared publication
Latest Publications
- Open Access
- 5 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (36) , e44301
Genetic evidence for causal associations between common cell-derived signaling molecules and sleep disorders and the mediating role of metabolites
Although the potential causal associations between cell-derived signaling molecules and sleep disorder (SD) have been reported, contradictions remain. This study assessed the causal effects and the mediating role of 1400 metabolites among 91 cell-derived signaling molecules and SD from a genetic perspective by performing Mendelian randomization (MR) analyses. Genetic instruments derived from publicly available genome-wide association studies were employed in this study, including 49,880 SD cases and 358,194 controls. Summary statistics of 1400 circulating metabolites were obtained from a cohort of 8299 individuals. The 91 cell-derived signaling molecules were derived from genome-wide association studies data from 11 cohorts comprising 14,824 samples. Multiple statistical analyses were introduced in this study, with inverse variance weighted as the core analysis method, supplemented by 4 additional methods. Besides, various sensitivity analyses were employed to identify horizontal pleiotropy and heterogeneity, thereby evaluating the robustness of the results. Forward MR analysis indicated positive associations between SD and the levels of eotaxin (OR = 1.041, 95% CI: 1.001–1.084, P = .046), CUB domain-containing protein 1 (OR = 1.042, 95% CI: 1.008–1.077, P = .016), interleukin-20 receptor subunit alpha (IL-20RA) (OR = 1.086, 95% CI: 1.031–1.143, P = .002), while the levels of CD40L receptor (OR = 0.968, 95% CI: 0.942–0.994, P = .018), glial cell line-derived neurotrophic factor (OR = 0.947, 95% CI: 0.910–0.986, P = .009) act as the opposite. Reverse MR analysis pointed out that the genetic susceptibility to SD raised interleukin-5 levels. According to the mediation analysis, N-lactoyl-tyrosine levels mediated the increased risks of SD associated with elevated IL-20RA levels, with a mediation effect of 0.009 (95% CI: 0.001–0.018, P = .034), accounting for 11.5% of the total. The study proved the causal associations between 91 cell-derived signaling molecules and SD, confirming that eotaxin, CUB domain-containing protein 1, and IL-20RA may increase the risk of SD, while CD40L receptor and glial cell line-derived neurotrophic factor may act as the opposite. Besides, the study provided abundant evidence for the potential mediating effect of N-lactoyl-tyrosine in the pathway linking IL-20RA and SD risk. To summarize, the findings of this study may benefit the understanding of the pathogenic mechanisms through which cell-derived signaling molecules influence SD.
- 5 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (36) , e44301
Open AccessGenetic evidence for causal associations between common cell-derived signaling molecules and sleep disorders and the mediating role of metabolites
Although the potential causal associations between cell-derived signaling molecules and sleep disorder (SD) have been reported, contradictions remain. This study assessed the causal effects and the mediating role of 1400 metabolites among 91 cell-derived signaling molecules and SD from a genetic perspective by performing Mendelian randomization (MR) analyses. Genetic instruments derived from publicly available genome-wide association studies were employed in this study, including 49,880 SD cases and 358,194 controls. Summary statistics of 1400 circulating metabolites were obtained from a cohort of 8299 individuals. The 91 cell-derived signaling molecules were derived from genome-wide association studies data from 11 cohorts comprising 14,824 samples. Multiple statistical analyses were introduced in this study, with inverse variance weighted as the core analysis method, supplemented by 4 additional methods. Besides, various sensitivity analyses were employed to identify horizontal pleiotropy and heterogeneity, thereby evaluating the robustness of the results. Forward MR analysis indicated positive associations between SD and the levels of eotaxin (OR = 1.041, 95% CI: 1.001–1.084, P = .046), CUB domain-containing protein 1 (OR = 1.042, 95% CI: 1.008–1.077, P = .016), interleukin-20 receptor subunit alpha (IL-20RA) (OR = 1.086, 95% CI: 1.031–1.143, P = .002), while the levels of CD40L receptor (OR = 0.968, 95% CI: 0.942–0.994, P = .018), glial cell line-derived neurotrophic factor (OR = 0.947, 95% CI: 0.910–0.986, P = .009) act as the opposite. Reverse MR analysis pointed out that the genetic susceptibility to SD raised interleukin-5 levels. According to the mediation analysis, N-lactoyl-tyrosine levels mediated the increased risks of SD associated with elevated IL-20RA levels, with a mediation effect of 0.009 (95% CI: 0.001–0.018, P = .034), accounting for 11.5% of the total. The study proved the causal associations between 91 cell-derived signaling molecules and SD, confirming that eotaxin, CUB domain-containing protein 1, and IL-20RA may increase the risk of SD, while CD40L receptor and glial cell line-derived neurotrophic factor may act as the opposite. Besides, the study provided abundant evidence for the potential mediating effect of N-lactoyl-tyrosine in the pathway linking IL-20RA and SD risk. To summarize, the findings of this study may benefit the understanding of the pathogenic mechanisms through which cell-derived signaling molecules influence SD.
- Open Access
- 6 September 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (36) , e39655
Association of MCP-4, NRTN, and PD-L1 with the risk of hepatic fibrosis: A Mendelian randomization study
Previous studies have confirmed the affiliation between specific inflammatory cytokines and Hepatic fibrosis (HF); however, contradictions remain in the causality. The study implemented a bidirectional two-sample Mendelian randomization (MR) analysis with published statistics derived from Genome-wide Association Studies (GWAS) to investigate casualties between inflammatory cytokines and HF. Additionally, MR analysis was also introduced to consider if 1400 blood metabolites act as the key mediators in this process. Single nucleotide polymorphisms (SNPs) with strong correlations to inflammatory factors were selected for multiple MR analyses in this study. The inverse variance weighted method (IVW) was chosen as the principal analysis, and the others as the supportive. Besides, sensitivity tests were involved to identify potential heterogeneity and pleiotropic level. IVW methods revealed that a relatively high level of prediction-based monocyte chemoattractant protein-4 (MCP-4) (95% CI: 1.014–3.336, P = .045), along with neurturin (NRTN) (95% CI: 1.204–4.004, P = .010), may increase the risk of HF; while programmed cell death 1 ligand 1 (PD-L1) (95% CI: 0.223–0.928, P = .030), showed a protective effect on HF. No significant statistical differences were detected on any other inflammatory cytokines, nor did the impact of HF genetic predisposition on the 91 circulating inflammatory cytokines-related characteristics.
- 6 September 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (36) , e39655
Open AccessAssociation of MCP-4, NRTN, and PD-L1 with the risk of hepatic fibrosis: A Mendelian randomization study
Previous studies have confirmed the affiliation between specific inflammatory cytokines and Hepatic fibrosis (HF); however, contradictions remain in the causality. The study implemented a bidirectional two-sample Mendelian randomization (MR) analysis with published statistics derived from Genome-wide Association Studies (GWAS) to investigate casualties between inflammatory cytokines and HF. Additionally, MR analysis was also introduced to consider if 1400 blood metabolites act as the key mediators in this process. Single nucleotide polymorphisms (SNPs) with strong correlations to inflammatory factors were selected for multiple MR analyses in this study. The inverse variance weighted method (IVW) was chosen as the principal analysis, and the others as the supportive. Besides, sensitivity tests were involved to identify potential heterogeneity and pleiotropic level. IVW methods revealed that a relatively high level of prediction-based monocyte chemoattractant protein-4 (MCP-4) (95% CI: 1.014–3.336, P = .045), along with neurturin (NRTN) (95% CI: 1.204–4.004, P = .010), may increase the risk of HF; while programmed cell death 1 ligand 1 (PD-L1) (95% CI: 0.223–0.928, P = .030), showed a protective effect on HF. No significant statistical differences were detected on any other inflammatory cytokines, nor did the impact of HF genetic predisposition on the 91 circulating inflammatory cytokines-related characteristics.